Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stafstrom

Showing results (71-80 of 244) with videos related to

Pageof 25
Sort By:
Epilepsia|June 20, 2020
2-Deoxyglucose terminates pilocarpine-induced status epilepticus in neonatal ratsRemi Janicot, Carl E Stafstrom, Li-Rong Shao
Developmental Neuroscience|November 27, 1999
Electrophysiological observations in hippocampal slices from rats treated with the ketogenic dietC E Stafstrom, C Wang, F E Jensen
Epilepsy & Behavior : E&B|May 5, 2012
Art therapy focus groups for children and adolescents with epilepsyCarl E Stafstrom, Janice Havlena, Anthony J Krezinski
Seminars in Pediatric Neurology|October 7, 2000
Consequences of epilepsy in the developing brain: implications for surgical managementC E Stafstrom, M Lynch, T P Sutula
Epilepsy Research|November 8, 2020
The efficacy of fructose-1,6-bisphosphate in suppressing status epilepticus in developing ratsRemi Janicot, Carl E Stafstrom, Li-Rong Shao
Neurology|August 31, 2023
Pearls & Oy-sters: Epilepsy Is a Key Feature of Pediatric-Onset Huntington DiseaseDawn B Lammert, Jee Bang, Carl E Stafstrom
Frontiers in Cellular Neuroscience|July 3, 2018
The Glycolytic Metabolite, Fructose-1,6-bisphosphate, Blocks Epileptiform Bursts by Attenuating Voltage-Activated Calcium Currents in Hippocampal SlicesLi-Rong Shao, Guangxin Wang, Carl E Stafstrom
Epilepsia|December 17, 2008
Seizure suppression via glycolysis inhibition with 2-deoxy-D-glucose (2DG)Carl E Stafstrom, Avtar Roopra, Thomas P Sutula
Neuroscience|September 17, 2025
Increased seizure susceptibility and neocortical excitability in TcMAC21 Down syndrome miceViveka Chinnasamy, Carl E Stafstrom, Li-Rong Shao
Frontiers in Neurology|April 4, 2017
Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber SyndromeCarl E Stafstrom, Verena Staedtke, Anne M Comi
Pageof 25

Showing results (71-80 of 244) with videos related to

Sort By:
Pageof 25
Epilepsia|June 20, 2020
2-Deoxyglucose terminates pilocarpine-induced status epilepticus in neonatal ratsRemi Janicot, Carl E Stafstrom, Li-Rong Shao
Developmental Neuroscience|November 27, 1999
Electrophysiological observations in hippocampal slices from rats treated with the ketogenic dietC E Stafstrom, C Wang, F E Jensen
Epilepsy & Behavior : E&B|May 5, 2012
Art therapy focus groups for children and adolescents with epilepsyCarl E Stafstrom, Janice Havlena, Anthony J Krezinski
Seminars in Pediatric Neurology|October 7, 2000
Consequences of epilepsy in the developing brain: implications for surgical managementC E Stafstrom, M Lynch, T P Sutula
Epilepsy Research|November 8, 2020
The efficacy of fructose-1,6-bisphosphate in suppressing status epilepticus in developing ratsRemi Janicot, Carl E Stafstrom, Li-Rong Shao
Neurology|August 31, 2023
Pearls & Oy-sters: Epilepsy Is a Key Feature of Pediatric-Onset Huntington DiseaseDawn B Lammert, Jee Bang, Carl E Stafstrom
Frontiers in Cellular Neuroscience|July 3, 2018
The Glycolytic Metabolite, Fructose-1,6-bisphosphate, Blocks Epileptiform Bursts by Attenuating Voltage-Activated Calcium Currents in Hippocampal SlicesLi-Rong Shao, Guangxin Wang, Carl E Stafstrom
Epilepsia|December 17, 2008
Seizure suppression via glycolysis inhibition with 2-deoxy-D-glucose (2DG)Carl E Stafstrom, Avtar Roopra, Thomas P Sutula
Neuroscience|September 17, 2025
Increased seizure susceptibility and neocortical excitability in TcMAC21 Down syndrome miceViveka Chinnasamy, Carl E Stafstrom, Li-Rong Shao
Frontiers in Neurology|April 4, 2017
Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber SyndromeCarl E Stafstrom, Verena Staedtke, Anne M Comi
Pageof 25